Original articleSynthesis and anticancer activity of some novel 2-phenazinamine derivatives

Add time:09/01/2019    Source:sciencedirect.com

In this study, we report the synthesis and spectral characterization of a novel series of 2-phenazinamine derivatives. In vitro evaluation for their anticancer activity toward cultured K562 (human chronic myelogenous leukemia), HepG2 (human hepatocellular carcinoma), MGC803 (human gastric carcinoma), HCT116 (human colorectal carcinoma), MCF7 (human breast adenocarcinoma) cell lines, as well as 293T (epithelial cells from human embryo kidney) non-cancer cell was carried out. The compounds 4, 7, 16 and 19 showed good positive anticancer activity in vitro. In particular, compound 4, 2-chloro-N-(phenazin-2-yl)benzamide, possessed a potent anticancer effect comparable to cisplatin against both K562 and HepG2 cancer cells but was very low or had no effect against 293T non-cancer cell. Preliminary anticancer mechanism of 4 was investigated by cell apoptosis assays compared with cisplatin using flow cytometry.

We also recommend Trading Suppliers and Manufacturers of 3-Methoxy-1-phenazinamine (cas 18450-06-1). Pls Click Website Link as below: cas 18450-06-1 suppliers

Prev:SHORT COMMUNICATIONSeparation and Determination of Madecassic acid (cas 18449-41-7) in Extracts of Centella asiatica Using High Performance Liquid Chromatography with β-Cyclodextrin as Mobile Phase Additive
Next:A novel pillared double-layered Pb(II) coordination polymer based on 1,3,5-benzenetricarboxylic acid and dipyrido[3,2-a:2′,3′-c]-Phenazine-2-carboxylic acid (cas 18450-16-3))